The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease

Fu, Y. P.; Kohaar, I.; Moore, L. E.; Lenz, P.; Figueroa, J. D.; Tang, W.; Porter-Gill, P.; Chatterjee, N.; Scott-Johnson, A.; Garcia-Closas, M.; Muchmore, B.; Baris, D.; Paquin, A.; Ylaya, K.; Schwenn, M.; Apolo, A. B.; Karagas, M. R.; Tarway, M.; Johnson, A.; Mumy, A.; Schned, A.; Guedez, L.; Jones, M. A.; Kida, M.; Hosain, G. M.; Malats, N.; Kogevinas, M.; Tardon, A.; Serra, C.; Carrato, A.; Garcia-Closas, R.; Lloreta, J.; Wu, X.; Purdue, M.; Andriole, G. L.; Grubb, R. L.; Black, A.; Landi, M. T.; Caporaso, N. E.; Vineis, P.; Siddiq, A.; Bueno-de-Mesquita, H. B.; Trichopoulos, D.; Ljungberg, B.; Severi, G.; Weiderpass, E.; Krogh, V.; Dorronsoro, M.; Travis, R. C.; Tjønneland, A.; Brennan, P.; Chang-Claude, J.; Riboli, E.; Prescott, J.; Chen, C.; De Vivo, I.; Govannucci, E.; Hunter, D.; Kraft, P.; Lindstrom, S.; Gapstur, S. M.; Jacobs, E. J.; Diver, W. R.; Albanes, D.; Weinstein, S. J.; Virtamo, J.; Kooperberg, C.; Hohensee, C.; Rodabough, R. J.; Cortessis, V. K.; Conti, D. V.; Gago Dominguez, Manuela; Stern, M. C.; Pike, M. C.; Van Den Berg, D.; Yuan, J. M.; Haiman, C. A.; Cussenot, O.; Cancel-Tassin, G.; Roupret, M.; Comperat, E.; Porru, S.; Carta, A.; Pavanello, S.; Arici, C.; Mastrangelo, G.; Grossman, H. B.; Wang, Z.; Deng, X.; Chung, C. C.; Hutchinson, A.; Burdette, L.; Wheeler, W.; Fraumeni, J.; Chanock, S. J.; Hewitt, S. M.; Silverman, D. T.; Rothman, N.; Prokunina-Olsson, L.

doi:10.1158/0008-5472.CAN-14-1531

Fu, Y. P.; Kohaar, I.; Moore, L. E.; Lenz, P.; Figueroa, J. D.; Tang, W.; Porter-Gill, P.; Chatterjee, N.; Scott-Johnson, A.; Garcia-Closas, M.; Muchmore, B.; Baris, D.; Paquin, A.; Ylaya, K.; Schwenn, M.; Apolo, A. B.; Karagas, M. R.; Tarway, M.; Johnson, A.; Mumy, A.; Schned, A.; Guedez, L.; Jones, M. A.; Kida, M.; Hosain, G. M.; Malats, N.; Kogevinas, M.; Tardon, A.; Serra, C.; Carrato, A.; Garcia-Closas, R.; Lloreta, J.; Wu, X.; Purdue, M.; Andriole, G. L.; Grubb, R. L.; Black, A.; Landi, M. T.; Caporaso, N. E.; Vineis, P.; Siddiq, A.; Bueno-de-Mesquita, H. B.; Trichopoulos, D.; Ljungberg, B.; Severi, G.; Weiderpass, E.; Krogh, V.; Dorronsoro, M.; Travis, R. C.; Tjønneland, A.; Brennan, P.; Chang-Claude, J.; Riboli, E.; Prescott, J.; Chen, C.; De Vivo, I.; Govannucci, E.; Hunter, D.; Kraft, P.; Lindstrom, S.; Gapstur, S. M.; Jacobs, E. J.; Diver, W. R.; Albanes, D.; Weinstein, S. J.; Virtamo, J.; Kooperberg, C.; Hohensee, C.; Rodabough, R. J.; Cortessis, V. K.; Conti, D. V.; Gago Dominguez, Manuela; Stern, M. C.; Pike, M. C.; Van Den Berg, D.; Yuan, J. M.; Haiman, C. A.; Cussenot, O.; Cancel-Tassin, G.; Roupret, M.; Comperat, E.; Porru, S.; Carta, A.; Pavanello, S.; Arici, C.; Mastrangelo, G.; Grossman, H. B.; Wang, Z.; Deng, X.; Chung, C. C.; Hutchinson, A.; Burdette, L.; Wheeler, W.; Fraumeni, J.; Chanock, S. J.; Hewitt, S. M.; Silverman, D. T.; Rothman, N.; Prokunina-Olsson, L.

Estadísticas

Ver Estadísticas de uso

Identificadores

URI: http://hdl.handle.net/20.500.11940/4605

PMID: 25320178

DOI: 10.1158/0008-5472.CAN-14-1531

ISSN: 0008-5472

Registro completo

Servicios

Visualización o descarga de ficheros

Texto completo disponible por cortesía de Cancer Res . 2014 Oct 15;74(20):5808-18. doi: 10.1158/0008-5472.CAN-14-1531. (1.119Mb)

Fecha de publicación

2014

Título de revista

CANCER RESEARCH

Tipo de contenido

Artigo

MeSH

Resumen

A genome-wide association study (GWAS) of bladder cancer identified a genetic marker rs8102137 within the 19q12 region as a novel susceptibility variant. This marker is located upstream of the CCNE1 gene, which encodes cyclin E, a cell-cycle protein. We performed genetic fine-mapping analysis of the CCNE1 region using data from two bladder cancer GWAS (5,942 cases and 10,857 controls). We found that the original GWAS marker rs8102137 represents a group of 47 linked SNPs (with r(2) >/= 0.7) associated with increased bladder cancer risk. From this group, we selected a functional promoter variant rs7257330, which showed strong allele-specific binding of nuclear proteins in several cell lines. In both GWASs, rs7257330 was associated only with aggressive bladder cancer, with a combined per-allele OR = 1.18 [95% confidence interval (CI), 1.09-1.27, P = 4.67 x 10(-5)] versus OR = 1.01 (95% CI, 0.93-1.10, P = 0.79) for nonaggressive disease, with P = 0.0015 for case-only analysis. Cyclin E protein expression analyzed in 265 bladder tumors was increased in aggressive tumors (P = 0.013) and, independently, with each rs7257330-A risk allele (P(trend) = 0.024). Overexpression of recombinant cyclin E in cell lines caused significant acceleration of cell cycle. In conclusion, we defined the 19q12 signal as the first GWAS signal specific for aggressive bladder cancer. Molecular mechanisms of this genetic association may be related to cyclin E overexpression and alteration of cell cycle in carriers of CCNE1 risk variants. In combination with established bladder cancer risk factors and other somatic and germline genetic markers, the CCNE1 variants could be useful for inclusion into bladder cancer risk prediction models.

Repositorio digital RUNA